ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

KATALYST & Co. Healthcare Transformation Platform Launches with $10 Million in Funding

By: PRLog
Kat Marie Alvarez, RN, MBA, Founder & Chief Executive Officer of KATALYST & Co., announces a healthcare transformation and investment firm reshaping value-based care

PALM BEACH, Fla. - Oct. 29, 2025 - PRLog -- Kat Marie Alvarez, RN, MBA, a nationally recognized healthcare leader, today announced the launch of KATALYST & Co., an integrated platform that unites strategic advisory services, capital deployment, and global operational execution. The company begins operations with $10 million in funding to drive its mission of advancing healthcare transformation through innovation and accountability.

Alvarez, who founded the company's now clinical division Katalyst Health in 2018, has spent decades leading change across the healthcare landscape. Her experience includes more than $5 billion in healthcare transactions, $2.7 billion in profit and loss responsibility, and the management of more than 12 million health plan members.

"I founded KATALYST & Co. to serve as a performance multiplier that helps providers, payers, sponsors, and tech innovators grow intelligently, deliver responsibly, and scale sustainably. With the $10 million initial round of funding, KATALYST & Co. is poised to shape the next era of healthcare, improving efficiency and innovation while honoring patients and those who care for them."

For investors, including private equity firms and individual stakeholders, the platform delivers industry insight, market analysis, and operational expertise that ensures sustainable portfolio growth.

For payers, such as health plans and third-party administrators, KATALYST & Co. strengthens value-based care models to improve both financial and clinical outcomes.

For technology innovators, the firm provides commercialization support for health technology solutions, helping emerging technologies achieve scale and market readiness.

For provider groups, hospitals and healthcare systems, KATALYST & Co. helps design and implement strategies that elevate care delivery, operational efficiency, and patient experience.

A driving force behind KATALYST & Co.'s mission is the national shift toward value-based care (VBC), a model that rewards improved outcomes rather than the volume of services provided. As the Centers for Medicare & Medicaid Services (CMS) advances toward full VBC implementation by 2030, KATALYST & Co. equips organizations to adapt and thrive amid widespread industry disruption from artificial intelligence, policy shifts, consolidation, and competition.

To guide clients through this transformation, KATALYST & Co. delivers expertise in strategic growth, investment advisory, global business process outsourcing and care delivery support, end-to-end value-based care infrastructure through Katalyst Health, and AI-powered technology enablement.

"We believe healthcare is a right, not a privilege," said Alvarez. "That conviction guides every partnership we take on and every system we help build."

Andrew Kaplan, Partner at Bain Capital, added, "Kat has a unique set of experiences that reach across the payer and care delivery ecosystem. Her patient-first mindset, combined with deep insights for where the market is heading, has consistently added value across multiple important efforts. She brings clarity and momentum to every engagement."

Contact
KATALYST & Co
Media: Karolyn Raphael
***@wingermarketing.com

Photos: (Click photo to enlarge)

20250703 131441765 Ios


Source: KATALYST & Co

Read Full Story - KATALYST & Co. Healthcare Transformation Platform Launches with $10 Million in Funding | More news from this source

Press release distribution by PRLog

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.35
+0.59 (0.26%)
AAPL  273.67
+1.48 (0.54%)
AMD  213.43
+12.37 (6.15%)
BAC  55.27
+1.01 (1.86%)
GOOG  308.61
+4.86 (1.60%)
META  658.77
-5.68 (-0.85%)
MSFT  485.92
+1.94 (0.40%)
NVDA  180.99
+6.85 (3.93%)
ORCL  191.97
+11.94 (6.63%)
TSLA  481.20
-2.17 (-0.45%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.